KINDLY MD, INC. UNDERWRITING AGREEMENT 1,240,910 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • June 5th, 2024 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledJune 5th, 2024 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,240,910 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,240,910 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
MINGTENG INTERNATIONAL CORPORATION INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2024 • Mingteng International Corp Inc. • Metal doors, sash, frames, moldings & trim • New York
Contract Type FiledApril 23rd, 2024 Company Industry Jurisdiction
MASSIMO GROUP UNDERWRITING AGREEMENT 1,300,000 Shares of Common StockUnderwriting Agreement • April 4th, 2024 • Massimo Group • Miscellaneous transportation equipment • New York
Contract Type FiledApril 4th, 2024 Company Industry JurisdictionMassimo Group, a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I thereto (the “Underwriters”) 1,300,000 authorized but unissued shares (the “Firm Shares”) of common stock of the Company, $0.001 par value (the “Common Stock”). In addition, the Company proposes to sell to Craft Capital Management, LLC, as representative of the Underwriters (the “Representative”), upon the terms and conditions set forth in Section 5 hereof, up to an additional 195,000 unissued shares of Common Stock of the Company (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Representative Warrants (as defined below) and the Representative Warrant Shares (as defined below) are collectively referred to as the “Securities.”
MASSIMO GROUP UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • February 5th, 2024 • Massimo Group • Miscellaneous transportation equipment • New York
Contract Type FiledFebruary 5th, 2024 Company Industry JurisdictionMassimo Group, a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I thereto (the “Underwriters”) [●] authorized but unissued shares (the “Firm Shares”) of common stock of the Company, $0.001 par value (the “Common Stock”). In addition, the Company proposes to sell to Roth Capital Partners, LLC, as representative of the Underwriters (the “Representative”), upon the terms and conditions set forth in Section 5 hereof, up to an additional [●] unissued shares of Common Stock of the Company (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Representative Warrants (as defined below) and the Representative Warrant Shares (as defined below) are collectively referred to as the “Securities.”
KINDLY MD, INC. UNDERWRITING AGREEMENT 1,272,727 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • December 7th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledDecember 7th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,272,727 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,272,727 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
KINDLY MD, INC. UNDERWRITING AGREEMENT 1,272,727 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • November 27th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledNovember 27th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,272,727 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,272,727 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
KINDLY MD, INC. UNDERWRITING AGREEMENT 1,272,727 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • November 6th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledNovember 6th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,272,727 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,272,727 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
KINDLY MD, INC. UNDERWRITING AGREEMENT 1,272,727 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • October 26th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledOctober 26th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,272,727 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,272,727 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
UNDERWRITING AGREEMENTUnderwriting Agreement • October 13th, 2023 • La Rosa Holdings Corp. • Real estate agents & managers (for others) • New York
Contract Type FiledOctober 13th, 2023 Company Industry JurisdictionLa Rosa Holdings Corp., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of 1,000,000 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) to the several underwriters listed on Schedule A hereto (such underwriters, for whom Alexander Capital L.P. (“Alexander” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). ”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Over‐allotment Option”), on the terms set forth in Section 1(b) hereof, to purchase up to an additional 150,000 shares of Common Stock (the “Option Shares”) and together with the Firm Shares, the “Shares”), and the offering of such Shares is hereinafter called the “Offering”. The Company has also agreed to issue to the Representative the Representative’s Warrants (as defined in Section 1(c)),
KINDLY MD, INC. UNDERWRITING AGREEMENT 1,272,727 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • October 11th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledOctober 11th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of 1,272,727 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,272,727 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued purs
KINDLY MD, INC. UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One-Half of One Share of Common StockUnderwriting Agreement • September 20th, 2023 • Kindly MD, Inc. • Services-health services • New York
Contract Type FiledSeptember 20th, 2023 Company Industry JurisdictionKINDLY MD, INC., a Utah corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of [●] Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, with no par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase one-half of one share of common stock (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The [●] shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued pursuant to and
LA ROSA HOLDINGS CORP. UNDERWRITING AGREEMENTUnderwriting Agreement • September 1st, 2023 • La Rosa Holdings Corp. • Real estate agents & managers (for others) • New York
Contract Type FiledSeptember 1st, 2023 Company Industry JurisdictionLa Rosa Holdings Corp., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of [ ] shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) to the several underwriters listed on Schedule A hereto (such underwriters, for whom Alexander Capital L.P. (“Alexander” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). ”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Over-allotment Option”), on the terms set forth in Section 1(b) hereof, to purchase up to an additional [____] shares of Common Stock (the “Option Shares”) and together with the Firm Shares, the “Shares”), and the offering of such Shares is hereinafter called the “Offering”. The Company has also agreed to issue to the Representative the Representative’s Warrants (as defined in Section 1(c)), which
BULLFROG AI HOLDINGS, INC. UNDERWRITING AGREEMENT 1,297,318 Units, Each Consisting of One Share of Common Stock, One Warrant to Purchase One Share of Common Stock, and One Non-tradeable Warrant to Purchase One Share of Common StockUnderwriting Agreement • February 21st, 2023 • BullFrog AI Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 21st, 2023 Company Industry JurisdictionBULLFROG AI HOLDINGS, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital, LLC is acting as Representative (the “Representative”), an aggregate of 1,297,318 Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.00001 par value per share (the “Common Stock”); (ii) one tradeable warrant to purchase one share of Common Stock (the “Firm Tradeable Warrants”); and , and one non-tradeable warrant the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The 1,297,318 shares of Common Stock referred to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units and the Firm Warrants, the “Firm Securities.” The Firm Warrants shall be issued pursuant to and shall have the ri
LIPELLA PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 13th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 13th, 2022 Company Industry Jurisdiction
LIPELLA PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 8th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 8th, 2022 Company Industry Jurisdiction
LIPELLA PHARMACEUTICALS INC. UNDERWRITING AGREEMENTUnderwriting Agreement • October 24th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2022 Company Industry Jurisdiction
WETRADE GROUP INC UNDERWRITING AGREEMENTUnderwriting Agreement • June 9th, 2021 • WeTrade Group Inc. • Services-computer processing & data preparation • New York
Contract Type FiledJune 9th, 2021 Company Industry Jurisdiction
MECHANICAL TECHNOLOGY, INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • April 12th, 2021 • Mechanical Technology Inc • Measuring & controlling devices, nec • New York
Contract Type FiledApril 12th, 2021 Company Industry Jurisdiction
MECHANICAL TECHNOLOGY, INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • April 2nd, 2021 • Mechanical Technology Inc • Measuring & controlling devices, nec • New York
Contract Type FiledApril 2nd, 2021 Company Industry Jurisdiction
CUENTAS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2021 • Cuentas Inc. • Wholesale-groceries & related products • New York
Contract Type FiledFebruary 5th, 2021 Company Industry JurisdictionThe undersigned, Cuentas, Inc., a Florida corporation (the “Company”), hereby confirms its agreement (this “Agreement”) to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;”), for whom Maxim Group LLC is acting as representative (in such capacity, the “Representative”), an aggregate of 2,790,697 units (the “Firm Units” or “Units”) of the Company’s securities, and, at the election of the Representative, up to an additional 418,604 Option Shares (as defined herein and collectively with the shares of Common Stock underlying the Firm Units, the “Shares”), and/or up to an additional 418,604 Option Warrants (as defined herein and collectively with warrants underlying the Firm Units, the “Warrants”). Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and one Warrant. Each Warrant entitles the holder to purchase one share of C
GREENWICH LIFESCIENCES, INC. UNDERWRITING AGREEMENT ______ Shares of Common StockUnderwriting Agreement • September 9th, 2020 • Greenwich LifeSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 9th, 2020 Company Industry JurisdictionGREENWICH LIFESCIENCES, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Aegis Capital Corp. is acting as representative (the “Representative”), an aggregate of ______ authorized but unissued shares of common stock, par value $0.001 per share, (the “Common Stock”) of the Company (the “Firm Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional ______ shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares” or the “Securities”.
UNDERWRITING AGREEMENT between AVINGER, INC. and AEGIS CAPITAL CORP. as Representative of the Several UnderwritersUnderwriting Agreement • August 21st, 2020 • Avinger Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 21st, 2020 Company Industry JurisdictionThe undersigned, Avinger, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”), and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
GREENWICH LIFESCIENCES, INC. UNDERWRITING AGREEMENT ______ Shares of Common StockUnderwriting Agreement • June 23rd, 2020 • Greenwich LifeSciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 23rd, 2020 Company Industry JurisdictionGREENWICH LIFESCIENCES, INC., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Aegis Capital Corp. is acting as representative (the “Representative”), an aggregate of ______ authorized but unissued shares of common stock, par value $0.001 per share, (the “Common Stock”) of the Company (the “Firm Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional ______ shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares” or the “Securities”.
SHARES OF COMMON STOCK AND [__] WARRANTS (EXERCISABLE FOR [__] SHARES) OF TOUGHBUILT INDUSTRIES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • January 17th, 2020 • Toughbuilt Industries, Inc • Cutlery, handtools & general hardware • New York
Contract Type FiledJanuary 17th, 2020 Company Industry JurisdictionThe undersigned, TOUGHBUILT INDUSTRIES, INC., a company incorporated under the laws of Nevada (collectively with its subsidiaries and Affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or Affiliates of TOUGHBUILT INDUSTRIES, INC., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which MAXIM GROUP LLC is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • January 16th, 2020 • SolarMax Technology, Inc. • Retail-building materials, hardware, garden supply • New York
Contract Type FiledJanuary 16th, 2020 Company Industry Jurisdiction
●] Shares American Resources Corporation Underwriting AgreementUnderwriting Agreement • February 6th, 2019 • American Resources Corp • Services-miscellaneous repair services • New York
Contract Type FiledFebruary 6th, 2019 Company Industry JurisdictionAmerican Resources Corporation, a Florida corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriter or underwriters, as the case may be, named in Schedule I hereto (each, an “Underwriter” and, collectively, the “Underwriters;” in the event that only a sole Underwriter is named on Schedule I hereto, then all references to “Underwriters” shall be deemed to mean and refer to such sole Underwriter), for whom Maxim Group LLC (“Maxim”) is acting as the representative (the “Representative”), an aggregate of [●] shares (the “Firm Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”). The Company has also agreed to grant to the Representative on behalf of the Underwriters an option (the “Option”) to purchase up to an additional shares (the “Optional Shares”) of Common Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 1(b) hereof
THE LOVESAC COMPANY UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • June 25th, 2018 • Lovesac Co • Retail-furniture stores • New York
Contract Type FiledJune 25th, 2018 Company Industry JurisdictionThe Lovesac Company, a Delaware corporation (such entity and, with respect to any time, date or period prior to the effective time of the Reorganization (as defined herein), SAC Acquisition LLC and any other predecessor entities of The Lovesac Company, and any subsidiaries of SAC Acquisition LLC or of any other predecessor entities of The Lovesac Company, the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”, or each, and “Underwriter”), for whom Roth Capital Partners, LLC is acting as the representative (the “Representative”) an aggregate of [●] authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.00001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional [●] shares of Common Stock (the “Option Shares”). The Firm Shares an